Pathophysiology, prevention, and treatment of medication overuse headache

Hans Christoph Diener, David Dodick, Stefan Evers, Dagny Holle, Rigmor Hoejland Jensen, Richard B. Lipton, Frank Porreca, Stephen Silberstein, Todd Schwedt

Research output: Contribution to journalReview article

4 Citations (Scopus)

Abstract

Regular or frequent use of analgesics and acute antimigraine drugs can increase the frequency of headache, and induce the transition from episodic to chronic headache or medication overuse headache. The 1-year prevalence of this condition in the general population is between 1% and 2%. Medication overuse headache is more common in women and in people with comorbid depression, anxiety, and other chronic pain conditions. Treatment of medication overuse headache has three components. First, patients need education and counselling to reduce the intake of medication for acute headache attacks. Second, some patients benefit from drug withdrawal (discontinuation of the overused medication). Finally, preventive drug therapy and non-medical prevention might be necessary in patients at onset of treatment or in patients who do not respond to the first two steps. The optimal therapeutic approach requires validation in controlled trials.

Original languageEnglish (US)
Pages (from-to)891-902
Number of pages12
JournalThe Lancet. Neurology
Volume18
Issue number9
DOIs
StatePublished - Sep 1 2019

Fingerprint

Secondary Headache Disorders
Headache
Headache Disorders
Patient Education
Chronic Pain
Pharmaceutical Preparations
Analgesics
Counseling
Therapeutics
Anxiety
Depression
Drug Therapy
Population

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Diener, H. C., Dodick, D., Evers, S., Holle, D., Jensen, R. H., Lipton, R. B., ... Schwedt, T. (2019). Pathophysiology, prevention, and treatment of medication overuse headache. The Lancet. Neurology, 18(9), 891-902. https://doi.org/10.1016/S1474-4422(19)30146-2

Pathophysiology, prevention, and treatment of medication overuse headache. / Diener, Hans Christoph; Dodick, David; Evers, Stefan; Holle, Dagny; Jensen, Rigmor Hoejland; Lipton, Richard B.; Porreca, Frank; Silberstein, Stephen; Schwedt, Todd.

In: The Lancet. Neurology, Vol. 18, No. 9, 01.09.2019, p. 891-902.

Research output: Contribution to journalReview article

Diener, HC, Dodick, D, Evers, S, Holle, D, Jensen, RH, Lipton, RB, Porreca, F, Silberstein, S & Schwedt, T 2019, 'Pathophysiology, prevention, and treatment of medication overuse headache', The Lancet. Neurology, vol. 18, no. 9, pp. 891-902. https://doi.org/10.1016/S1474-4422(19)30146-2
Diener, Hans Christoph ; Dodick, David ; Evers, Stefan ; Holle, Dagny ; Jensen, Rigmor Hoejland ; Lipton, Richard B. ; Porreca, Frank ; Silberstein, Stephen ; Schwedt, Todd. / Pathophysiology, prevention, and treatment of medication overuse headache. In: The Lancet. Neurology. 2019 ; Vol. 18, No. 9. pp. 891-902.
@article{880ce462ef9842e1a92f74ae383d728c,
title = "Pathophysiology, prevention, and treatment of medication overuse headache",
abstract = "Regular or frequent use of analgesics and acute antimigraine drugs can increase the frequency of headache, and induce the transition from episodic to chronic headache or medication overuse headache. The 1-year prevalence of this condition in the general population is between 1{\%} and 2{\%}. Medication overuse headache is more common in women and in people with comorbid depression, anxiety, and other chronic pain conditions. Treatment of medication overuse headache has three components. First, patients need education and counselling to reduce the intake of medication for acute headache attacks. Second, some patients benefit from drug withdrawal (discontinuation of the overused medication). Finally, preventive drug therapy and non-medical prevention might be necessary in patients at onset of treatment or in patients who do not respond to the first two steps. The optimal therapeutic approach requires validation in controlled trials.",
author = "Diener, {Hans Christoph} and David Dodick and Stefan Evers and Dagny Holle and Jensen, {Rigmor Hoejland} and Lipton, {Richard B.} and Frank Porreca and Stephen Silberstein and Todd Schwedt",
year = "2019",
month = "9",
day = "1",
doi = "10.1016/S1474-4422(19)30146-2",
language = "English (US)",
volume = "18",
pages = "891--902",
journal = "The Lancet Neurology",
issn = "1474-4422",
publisher = "Lancet Publishing Group",
number = "9",

}

TY - JOUR

T1 - Pathophysiology, prevention, and treatment of medication overuse headache

AU - Diener, Hans Christoph

AU - Dodick, David

AU - Evers, Stefan

AU - Holle, Dagny

AU - Jensen, Rigmor Hoejland

AU - Lipton, Richard B.

AU - Porreca, Frank

AU - Silberstein, Stephen

AU - Schwedt, Todd

PY - 2019/9/1

Y1 - 2019/9/1

N2 - Regular or frequent use of analgesics and acute antimigraine drugs can increase the frequency of headache, and induce the transition from episodic to chronic headache or medication overuse headache. The 1-year prevalence of this condition in the general population is between 1% and 2%. Medication overuse headache is more common in women and in people with comorbid depression, anxiety, and other chronic pain conditions. Treatment of medication overuse headache has three components. First, patients need education and counselling to reduce the intake of medication for acute headache attacks. Second, some patients benefit from drug withdrawal (discontinuation of the overused medication). Finally, preventive drug therapy and non-medical prevention might be necessary in patients at onset of treatment or in patients who do not respond to the first two steps. The optimal therapeutic approach requires validation in controlled trials.

AB - Regular or frequent use of analgesics and acute antimigraine drugs can increase the frequency of headache, and induce the transition from episodic to chronic headache or medication overuse headache. The 1-year prevalence of this condition in the general population is between 1% and 2%. Medication overuse headache is more common in women and in people with comorbid depression, anxiety, and other chronic pain conditions. Treatment of medication overuse headache has three components. First, patients need education and counselling to reduce the intake of medication for acute headache attacks. Second, some patients benefit from drug withdrawal (discontinuation of the overused medication). Finally, preventive drug therapy and non-medical prevention might be necessary in patients at onset of treatment or in patients who do not respond to the first two steps. The optimal therapeutic approach requires validation in controlled trials.

UR - http://www.scopus.com/inward/record.url?scp=85071349577&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071349577&partnerID=8YFLogxK

U2 - 10.1016/S1474-4422(19)30146-2

DO - 10.1016/S1474-4422(19)30146-2

M3 - Review article

C2 - 31174999

AN - SCOPUS:85071349577

VL - 18

SP - 891

EP - 902

JO - The Lancet Neurology

JF - The Lancet Neurology

SN - 1474-4422

IS - 9

ER -